Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

Fuente: International Business Times

Pharma companies were spared from Trump's tariff announcement last week. Since US President Donald Trump announced his sweeping tariff policies on 3rd April, the US stock market indexes have declined sharply, wiping out trillions of dollars of investor money. The deteriorating trade war faces more unpredictability as the tariffs go into effect today, and Trump increased the surcharge on China imports to 104% in response to the mainland's reciprocal tariffs.